Clinical Trials on Indication for PICC Placement in Belgium
Total 10 results
-
Universitaire Ziekenhuizen KU LeuvenCompletedPatients With Any Condition Who Need a PICC for IV TherapyBelgium
-
University Hospital, GhentCompletedIndications for a Total Hip ProsthesisBelgium
-
University Hospital, GhentCompletedIndications for a Total Hip ProsthesisBelgium
-
AZ-VUBUnknownCancers Harbouring an EGFR Mutation, (Excluding Non-squamous Non- Small Cell Lung Cancer, a Registered Indication), a HER2 Mutation or a HER3 MutationBelgium
-
Gigi VeeremanCompletedDescription of Disease Course, Disease Fenotype, Medication, Safety, Analysis for Possible AssociationsBelgium
-
Genzyme, a Sanofi CompanyCompletedSphingomyelin LipidosisUnited States, Belgium, Brazil, France, Germany, Italy, United Kingdom
-
MicroPort CRMActive, not recruitingInappropriate Shocks From Implanted Defibrillator | ICD Replacement or UpgradeNetherlands, United States, France, Spain, Belgium, Switzerland, Italy, United Kingdom, Germany, Austria, Portugal
-
Genzyme, a Sanofi CompanyCompletedSphingomyelin LipidosisUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Chile, France, Germany, Italy, Japan, Netherlands, Portugal, Spain, Tunisia, Turkey, United Kingdom
-
SanofiCompletedSphingomyelin LipidosisItaly, Czechia, Belgium, France, Portugal, Turkey, United States, Argentina, Brazil, Chile, Germany, Romania, Spain
-
Universitaire Ziekenhuizen KU LeuvenNorwegian Institute of Public Health; KU Leuven; University Ghent; SciensanoCompletedLiver Diseases | Cardiovascular Diseases | Sexually Transmitted Diseases | Hypertension | Obesity | Diabetes Mellitus | Fatigue | Chronic Kidney Diseases | Thyroid Diseases | Rheumatoid Arthritis | Diarrhea | Anemia | Acute Coronary Syndrome | Gout | Lung Embolism | Medication Monitoring | General Check-upBelgium